Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Correct: The correct numbers are provided below. The authors sincerely apologize for this oversight

Detalles Bibliográficos
Autores: Perez, Marco, Lucena Cacace, Antonio, Marín Gómez, Luis Miguel, Padillo Ruiz, Francisco Javier, Robles Frias, MJ, Saez, Carmen, García Carbonero, Rocío, Carnero Moya, Amancio
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/175516
Acceso en línea:https://hdl.handle.net/11441/175516
https://doi.org/10.18632/oncotarget.13482
Access Level:acceso abierto
id ES_7ca74c6d320e615bf71095b33ac40d0c
oai_identifier_str oai:idus.us.es:11441/175516
network_acronym_str ES
network_name_str España
repository_id_str
spelling Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-SrcPerez, MarcoLucena Cacace, AntonioMarín Gómez, Luis MiguelPadillo Ruiz, Francisco JavierRobles Frias, MJSaez, CarmenGarcía Carbonero, RocíoCarnero Moya, AmancioCorrect: The correct numbers are provided below. The authors sincerely apologize for this oversightImpact JournalsCirugíaCTS664: Cirugía Avanzada y Trasplantes. Terapia Celular y Bioingeniería Aplicada a la Cirugía2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/11441/175516https://doi.org/10.18632/oncotarget.13482reponame:idUS. Depósito de Investigación de la Universidad de Sevillainstname:Universidad de Sevilla (US)InglésOncotarget, 7 (37), 78219.Perez, M., Lucena Cacace, A., Marín Gómez, L.M., Padillo Ruiz, F.J., Robles Frias, M., Saez, C.,...,Carnero Moya, A. (2016). Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.. Oncotarget, 7 (22), 33111-33124.https://hdl.handle.net/11441/95985https://www.oncotarget.com/article/13482/pdf/info:eu-repo/semantics/openAccessoai:idus.us.es:11441/1755162026-06-17T12:51:07Z
dc.title.none.fl_str_mv Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
spellingShingle Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
Perez, Marco
title_short Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_full Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_fullStr Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_full_unstemmed Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
title_sort Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src
dc.creator.none.fl_str_mv Perez, Marco
Lucena Cacace, Antonio
Marín Gómez, Luis Miguel
Padillo Ruiz, Francisco Javier
Robles Frias, MJ
Saez, Carmen
García Carbonero, Rocío
Carnero Moya, Amancio
author Perez, Marco
author_facet Perez, Marco
Lucena Cacace, Antonio
Marín Gómez, Luis Miguel
Padillo Ruiz, Francisco Javier
Robles Frias, MJ
Saez, Carmen
García Carbonero, Rocío
Carnero Moya, Amancio
author_role author
author2 Lucena Cacace, Antonio
Marín Gómez, Luis Miguel
Padillo Ruiz, Francisco Javier
Robles Frias, MJ
Saez, Carmen
García Carbonero, Rocío
Carnero Moya, Amancio
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Cirugía
CTS664: Cirugía Avanzada y Trasplantes. Terapia Celular y Bioingeniería Aplicada a la Cirugía
description Correct: The correct numbers are provided below. The authors sincerely apologize for this oversight
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/11441/175516
https://doi.org/10.18632/oncotarget.13482
url https://hdl.handle.net/11441/175516
https://doi.org/10.18632/oncotarget.13482
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Oncotarget, 7 (37), 78219.
Perez, M., Lucena Cacace, A., Marín Gómez, L.M., Padillo Ruiz, F.J., Robles Frias, M., Saez, C.,...,Carnero Moya, A. (2016). Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.. Oncotarget, 7 (22), 33111-33124.
https://hdl.handle.net/11441/95985
https://www.oncotarget.com/article/13482/pdf/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Impact Journals
publisher.none.fl_str_mv Impact Journals
dc.source.none.fl_str_mv reponame:idUS. Depósito de Investigación de la Universidad de Sevilla
instname:Universidad de Sevilla (US)
instname_str Universidad de Sevilla (US)
reponame_str idUS. Depósito de Investigación de la Universidad de Sevilla
collection idUS. Depósito de Investigación de la Universidad de Sevilla
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411606675324929
score 15.812429

Similares en LA Referencia